Skip to main content

Table 3 Mean difference in primary and secondary outcome at T0 (baseline), T1 (after intervention) and T2 (follow-up) in the experimental/control groups

From: Group meta-cognitive therapy and depression in women with breast cancer: a randomized controlled trial

Variable

Group

T0

M (SD)

T1

M (SD)

p value

T2

M (SD)

p value

Depression

Experimental

21.16 (4.83)

15.58 (8.50)

0.025a

12.83 (88.21)

0.016b

Control

22.66 (5.34)

23.16 (8.89)

0.969a

25.75 (8.22)

0 .285b

p value

0.416c

0.073c

 

0.006c

 

CE regulation

Experimental

105 (14.72)

108.41 (15.80)

0.442a

111.08 (23.30)

0.480b

Control

108 (13.08)

111.58 (11.56)

0.102a

110.16 (7.76)

0.656b

p value

0.644c

0.644c

 

0.908c

 

M C beliefs

Experimental

79.51 (10.72)

72.66 (11.42)

0.050a

68.72 (15.74)

0.006b

Control

76.33 (12.08)

76.01 (11.62)

0.769a

77/91 (12.94)

0.906b

p value

0.506c

0.488c

 

0.088c

 
  1. aWilcoxon test
  2. bWilcoxon test (compare T0 to T2)
  3. cMann Whitney test